RIP-seq vs CLIP-seq: What Is the Difference?

RIP-seq immunoprecipitates a protein under native conditions and sequences the co-purifying RNA. It reports which transcripts are associated, at transcript-level resolution, with substantial background from indirect associations.

CLIP-seq (and its variants) uses UV crosslinking to covalently link protein to RNA at the contact point, followed by partial RNase digestion and sequencing. It reports where on the transcript the protein binds, at near-nucleotide resolution, with far lower background.

If you need a target list, RIP is adequate. If you need binding sites, use CLIP.

Without crosslinking, the immunoprecipitate contains RNAs that were near the protein rather than bound by it. Highly abundant transcripts appear in nearly every RIP, and ribosomal RNA contamination is routine.

Mitigation: rigorous washes, spike-in controls, comparison against an isotype or tagged-empty control, and validation of top hits by an independent method. Even with these, RIP cannot distinguish direct from indirect association.

CLIP variants improve resolution but introduce their own biases:

• • HITS-CLIP relies on UV crosslink sites that produce deletions or mutations in cDNA; detection depends on reverse transcriptase behaviour.
• • PAR-CLIP uses 4-thiouridine incorporation, which requires metabolic labeling and can alter RNA biology.
• • iCLIP/eCLIP add barcode and input controls, improving quantification and allowing peak calling with statistical support.

Practical guidance: for a new protein, run eCLIP-style with size-matched input; report reproducibility across replicates and the fraction of peaks supported by a motif or structural element.

Both methods establish association. A binding site without a functional consequence is a real and reportable observation, but it is not regulation.

The functional step is a perturbation: mutate the binding site, deplete the protein, or tether it, then measure the predicted consequence (stability, splicing, translation, localization). Reporting binding and function separately is the honest structure, and it is what distinguishes mechanism papers from catalogue papers.

EDITGENE builds the follow-up: isogenic binding-site mutations, tethering lines for sufficiency, RBP knockout and degron lines with protein-level validation, and stability or splicing readouts matched to the predicted mechanism.

Tell us the RBP and the candidate site. Contact EDITGENE to request a project consultation or quote.

Performance of both methods depends on antibody quality, crosslinking efficiency, input, and analysis; peak sets are not directly comparable across studies without matched processing.

Binding data establish association, not regulation. Functional claims require perturbation with appropriate controls.

• • Ule J, et al. CLIP identifies Nova-regulated RNA networks in the brain. Science. 2003;302:1212–1215.
• • Van Nostrand EL, et al. Robust transcriptome-wide discovery of RNA-binding protein binding sites with enhanced CLIP (eCLIP). Nature Methods. 2016;13:508–514.
• • Hafner M, et al. Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell. 2010;141:129–141.
• • Wheeler EC, et al. Advances and challenges in the detection of transcriptome-wide protein–RNA interactions. WIREs RNA. 2018;9:e1436.